SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
RYAN STEPHEN J

(Last) (First) (Middle)
2525 DUPONT DRIVE

(Street)
IRVINE CA 92612

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALLERGAN INC [ AGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/03/2012 M 5,000 A $36.85 53,451.819 D
Common Stock 08/03/2012 M 5,000 A $45.885 58,451.819 D
Common Stock 08/03/2012 M 5,000 A $36.49 63,451.819 D
Common Stock 08/03/2012 S 15,000 D $86.5037 (1) 48,451.819 D
Common Stock 08/06/2012 M 9,000 A $51.715 57,451.819 D
Common Stock 08/06/2012 M 6,900 A $54.32 64,351.819 D
Common Stock 08/06/2012 S 15,900 D $85.4672 (2) 48,451.819 D
Common Stock 08/07/2012 M 4,500 A $54.32 52,951.819 D
Common Stock 08/07/2012 M 11,400 A $46.66 64,351.819 D
Common Stock 08/07/2012 S 15,900 D $85.3452 (3) 48,451.819 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Nonemployee Director Stock Option (Right to Buy) $36.85 08/03/2012 M 5,000 04/25/2004 04/24/2013 Common Stock 5,000 $0 0 D
Nonemployee Director Stock Option (Right to Buy) $45.88 08/03/2012 M 5,000 04/28/2005 04/28/2014 Common Stock 5,000 $0 0 D
Nonemployee Director Stock Option (Right to Buy) $36.49 08/03/2012 M 5,000 04/26/2006 04/26/2015 Common Stock 5,000 $0 0 D
Nonemployee Director Stock Option (Right to Buy) $51.71 08/06/2012 M 9,000 05/02/2007 05/02/2016 Common Stock 9,000 $0 0 D
Nonemployee Director Stock Option (Right to Buy) $54.32 08/06/2012 M 6,900 (4) 05/06/2018 Common Stock 6,900 $0 4,500 D
Nonemployee Director Stock Option (Right to Buy) $54.32 08/07/2012 M 4,500 (4) 05/06/2018 Common Stock 4,500 $0 0 D
Nonemployee Director Stock Option (Right to Buy) $46.66 08/07/2012 M 11,400 (5) 04/30/2019 Common Stock 11,400 $0 0 D
Explanation of Responses:
1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.4375 to $86.5700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.1500 to $85.6100, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.0700 to $85.6700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
4. Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.
5. Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.
/s/ Matthew J. Maletta, Attorney-in-Fact for Stephen J. Ryan 08/07/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.